Recursion Pharmaceuticals, Inc. RXRX

US Biotechnology

$3.64 ▼ -4.34% ($-0.17)

🔥 High Short Interest

Open $3.75

Prev Close $3.81

Day Range $3.57 – $3.78

52W Range $2.77 – $5.24

Market Cap $2.19B

Beta 1.23

EPS (TTM) $-0.89

📋 Company Profile

Industry	Biotechnology
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	2021-04-16
Shares Out.	594,730,000
Website	recursion.com/ ↗
Phone	13026744089
Employees	600
Revenue	$18.6M
Gross Profit	$8.5M
Net Income	-$119.0M
Free Cash Flow	-$312.5M
Total Assets	$1.22B
Total Liabilities	$315.9M
Equity	$905.8M

About Recursion Pharmaceuticals, Inc.

Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Geographically, the company operates in United States, United Kingdom, and Others. It derives maximum revenue from United States.

Recursion Pharmaceuticals, Inc. is a publicly traded company under the ticker symbol RXRX on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.